• Gouri Rohit Dixit Sharad Pawar College of Pharmacy, Nagpur
  • Mathur V B


This study reviews that solubilization of lipophilic drugs with low aqueous solubility has been a major trust area in recent years. It can be seen that
there is a real and continuing need for the development of effective drug delivery systems for poorly water-soluble drugs to enhance their absorption
and bioavailability. One such approach might be pharmaceutical microemulsions as they have emerged as potential solubility enhancing technologies.
Microemulsion system has considerable potential to act as a drug delivery vehicle by incorporating a wide range of drug molecules. Microemulsion
has got advantage like excellent thermodynamic stability, high drug solubilization capacity, improved oral bioavailability and protection against
enzymatic hydrolysis. This review focuses on the basic concept, formulation, characterization, and recent advances in microemulsions as novel drug
delivery system.
Keywords: Microemulsion, Lipophilicity, Solubilization, Bioavailability, Phase behavior.


1. Aungst BJ. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J Pharm Sci 1993;82(10):979-87.
2. Talegaonkar S, Azeem A, Ahmad FJ, Khar RK, Pathan SA, Khan ZI. Microemulsions: A novel approach to enhanced drug delivery. Recent Pat Drug Deliv Formul 2008;2(3):238-57.
3. Mehta SK, Kaur G. Microemulsions as carriers for therapeutic molecules. Recent Pat Drug Deliv Formul 2010;4(1):35-48.
4. Nazzal S, Smalyukh II, Lavrentovich OD, Khan MA. Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: Mechanism and progress of emulsion formation. Int J Pharm 2002;235:247-65.
5. Ansari MJ, Kohli K, Dixit N. Microemulsions as potential drug delivery systems: A review. PDA J Pharm Sci Technol 2008;62:66-79.
6. Azeem A, Khan ZI, Aqil M, Ahmad FJ, Khar RK, Talegaonkar S. Microemulsions as a surrogate carrier for dermal drug delivery. Drug Dev Ind Pharm 2009;35(5):525-47.
7. Ghosh PK, Murthy RS. Microemulsions: A potential drug delivery system. Curr Drug Deliv 2006;3:167-80.
8. Karasulu HY. Microemulsions as novel drug carriers: The formation, stability, applications and toxicity. Expert Opin Drug Deliv 2008;5(1):119-35.
9. Sarkhejiya NA, Nakum MA, Patel VP, Atara SA, Desai TR. Emerging trend of microemulsion in formulation and research. Int Bull Drug Res 2012;1(1):54-83.
10. Hoar TP, Schulman JH. Transparent water-in-oil dispersions, the oleopathichydromicelle. Nature 1943;152:102-3.
11. Schulman JH, Stoeckenius W, Prince LM. Mechanism of formation and structure of micro emulsions by electron microscopy. J Phys Chem 1959;63:1677-80.
12. Shinoda K, Lindman B. Organised surfactant systems: Microemulsions. Langmuir 1987;3:135-49.
13. Bagwe RP, Kanicky JR, Palla BJ, Patanjali PK, Shah DO. Improved drug delivery using microemulsions: rationale, recent progress, and new horizons. Crit Rev Ther Drug Carrier Syst 2001;18(1):77-140.
14. Dhanapal R. A review – Microemulsion. Asian J Pharm Res 2012;2(1):23-9.
15. Lam AC, Schechter RS. The theory of diffusion in microemulsions. J Colloid Interface Sci 1987;120:56-63.
16. Lipka E, Amidon GL. Setting bioequivalence requirements for drug development based on preclinical data: Optimizing oral drug delivery systems. J Control Release 1999;62(1-2):41-9.
17. Prince LM. A theory of aqueous emulsion I. Negative interfacial tension at the oil/water interface. J Colloid Interface Sci 1967;23:165-73.
18. Shinoda, K, Friberg S, Microemulsions: Colloidal aspects. Adv Colloid Interface Sci 1975;4:281-300.
19. Kimura M, Shizuki M, Miyoshi K, Sakai T, Hidaka H, Takamura H, et al. Relationship between the molecular structures and emulsification properties of edible oils. Biosci Biotech Biochem 1994;58:1258-61.
20. Strickley RG. Solubilising excipients in oral and injectable formulations. Pharm Res 2004;21:201-30.
21. Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. Int J Pharm 2007;345(1-2):9-25.
22. Roux D, Coulon C. Modelling interactions in microemulsion phases. J Physique 1986;47:1257-64.
23. Rao YS, Deepthi KS, Chowdary KP, Microemulsions: A novel drug carrier system. Int J Drug Dev Tech 2009;1:39-41.
24. Shafiq-un-Nabi S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, et al. Formulation development and optimization using nanoemulsion technique: A technical note. AAPS Pharm Sci Tech 2007;8(2):E12-7.
25. Rosano HL, Cavello JL, Chang DL, Whittham JH, Microemulsions: A commentary on their preparation. J Soc Cosm Chem 1988;39:201-9.
26. Kunieda H, Asaoka H, Shinoda K. Two types of surfactant phases and four coexisting liquid phases in a water/non-ionic surfactant/triglyceride/hydrocarbon system. J Phys Chem 1988;92(1):185-9.
27. Winsor PA. Hydrotropy, solubilisation and related emulsification processes. J Chem Soc Faraday Trans 1948;44(1):376-98.
28. Bellare JR, Haridas MM, Li XJ. Characterization of microemulsions using fast freeze fracture and cry-electron microscopy. In: Kumar P, Mittal KL, editors. Handbook of Microemulsion Science and Technology. New York: Marcel Dekker; 1999. p. 411-35.
29. Danino D, Bernheim-Groswasser A, Talmon Y. Digital cryogenic transmission electron microscopy: An advanced tool for direct imaging of complex fluids. COLLOIDS surf A Physicochem Eng Asp 2001;113(22):183–5.
30. Carlfors J, Blute I, Schmidt V. Lidocaine in microemulsions: A dermal delivery system. J Dispers Sci Technol 1991;12:467-82.
31. Rushforth DS, Sanchez-Rubio M, Santos Vidals LM, Wormuth KR, Kaler EW, Cuevas R, et al. Structural study of one-phase microemulsions. J Phys Chem 1986;90:6668-73.
32. Subramanian N, Ghosal SK, Moulik SP. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion. Drug Dev Ind Pharm 2005;31:405-16.
33. Vyas SP, Khar RK. Submicron emulsions, eds. Targeted and Controlled DrugDelivery – Novel Carrier Systems. New Delhi, India: CBS Publishers; 2002. p. 282-302.
34. Ho HO, Hsiao CC, Sheu MT. Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs. J Pharm Sci 1996;85(2):138-43.
35. von Corswant C, Thorén P, Engström S. Triglyceride-based microemulsion for intravenous administration of sparingly soluble substances. J Pharm Sci 1998;87:200-8.
36. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 1997;45:131-40.
37. Fialho SL, da Silva Cunha A. New vehicle based on a microemulsion for topicalocular administration of dexamethasone. Clin Exp Ophthalmol 2004;32:626-32.
38. Lv FF, Li N, Zheng LQ, Tung CH. Studies on the stability of the chloramphenicol in the microemulsion free of alcohols. Eur J Pharm Biopharm 2006;62(3):288-94.
39. Gupta S, Moulik SP. Biocompatible microemulsions and their prospective uses indrug delivery. J Pharm Sci 2008;97(1):22-45.
40. Li IL, Nandi I, Kim KH. Development of an ethyl laurate based microemulsionfor rapid onset of intranasal delivery of diazepam. Int J Pharm 2002;237(1-2):77-85.
41. Shiokawa T, Hattori Y, Kawano K, Ohguchi Y, Kawakami H, Toma K, et al. Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res 2005;11(5):2018-25.
Asian J Pharm Clin Res, Vol 8, Issue 5, 2015, 7-17
Dixit and Mathur
42. Brodin A, Fynes R, Heijl R, Nyqvist-Mayer, Scherlund M. United States Patent, US20006031007, 2000.
43. Monahan SD, Wolff JA, Slattum PM, Hagstrom JE, Budker VG. United States Patent, US20026429200, 2002.
44. Maranhao RC. United States Patent, US5578583, 1996.
45. Dorman DC, Brenneman KA, Mc Elveen AM, Lynch SE, Roberts KC, Wong BA. Olfactory transport: A direct route of delivery of inhaled managanese phosphate to the rat brain J Toxicol Environ Health 2002;65(20):1493-511.
46. Draghia R, Caillaud C, Manicom R, Pavirani A, Kahn A, Poenaru L. Gene delivery into the central nervous system by nasal instillation in rats. Gene Ther 1995;2(6):418-23.
47. Wermeling DP, Miller JL, Archer SM, Manaligod JM, Rudy AC. Bioavailability and pharmacokinetics of lorazepam after intranasal, intravenous, and intramuscular administration. J Clin Pharmacol 2001;41(11):1225-31.
48. Hasse A, Keipert S. Development and characterisation of microemulsions for ocularapplication. Eur J Pharm Biopharm 1997;43:179-83.
49. Malmsten M. Microemulsions in pharmaceuticals. In: Handbook of Microemulsion, Science and Technology. New York: Marcel Dekker Inc.; 1999. p. 755-71.
50. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 20006;45(1):89-121.
549 Views | 802 Downloads
How to Cite
Dixit, G. R., and M. V B. “MICROEMULSIONS: PLATFORM FOR IMPROVEMENT OF SOLUBILITY AND DISSOLUTION OF POORLY SOLUBLE DRUGS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 5, Sept. 2015, pp. 7-17, https://innovareacademics.in/journals/index.php/ajpcr/article/view/6068.
Review Article(s)